ALS: U.S. FDA still skeptical of Amylyx drug - CTV News

ALS: U.S. FDA still skeptical of Amylyx drug – CTV News

September 5, 2022
2:59 am

U.S. Federal health regulators remain unconvinced about the benefits of a closely watched experimental drug for the debilitating illness known as Lou Gehrig’s disease, even as they prepare to give its drugmaker a rare second opportunity to make a public case for the treatment.
Amylyx Pharmaceuticals’ experimental drug has become a rallying cause for patients with the deadly neurodegenerative disease, their families and members of Congress who are pushing the FDA to approve the drug.
But regulators said Friday that the drugmaker’s new analyses are not "sufficiently independent or persuasive" to establish effectiveness. The agency posted its review ahead of a Wednesday meeting of its outside advisers, who will vote on whether to recommend approval.
In March, the same panel of neurological experts voted 6-4 that the company’s data failed to show a convincing benefit for ALS, or amyotrophic lateral sclerosis. It’s extremely rare for the FDA to call a second review meeting after its advisers have already voted.
The FDA will ask the panel to review several new statistical analyses, which the company says strengthen the case that its drug prolongs life and delays hospitalization and other severe complications. The FDA says the experts can take into account "the unmet need in ALS," the disease’s seriousness and other factors specific to the terminal diseases.
Elsewhere in its review the FDA detailed the flexibility it can apply to drug approval decisions, particularly for deadly diseases, which suggests "there is a chance that the FDA is still looking for a way to approve the product," SVB analyst Marc Goodman wrote in a note to investors. He gives Amylyx a 50% chance of approval.
ALS destroys nerve cells needed to walk, talk, swallow and — eventually — breathe. There is no cure and most people die within three to five years.
The FDA’s review reflects some of the biggest questions facing the agency, including: How strict should it be in enforcing approval standards for drugs against rare, fatal diseases? And how much weight, if any, should be given to outside appeals from patients, advocates and their political allies?
Typically, FDA approval requires two large studies or one study with a "very persuasive" effect on survival.
Amylyx’s data comes from one small, mid-stage trial that showed some benefit in slowing the disease, but which was marred by missing data, implementation errors and other problems, according to FDA reviewers.
Amylyx says follow-up data gathered after the study concluded shows the drug extended life. When the company followed patients who continued taking the drug, they survived about 10 months longer than patients who never took the drug, according to a new company analysis.
But FDA said Friday the new approach "suffers from the same interpretability challenges" as Amylyx’s initial study and that the new analysis "is not independent data."
The FDA does not publicly explain its rationale for holding meetings. But some outside analysts believe the agency is hoping that more external input will strengthen its hand when it renders its final decision, expected by the end of the month.
Amylyx’s drug is a combination of two older drug ingredients: a prescription medication for liver disorders and a dietary supplement associated with traditional Chinese medicine. The Cambridge, Massachusetts, company has patented the combination and says the chemicals work together to shield cells from premature death. Its co-founders first hit upon the combination as Brown University students.
Some ALS patients already take both pills. FDA approval would likely compel insurers to cover the treatment.
The FDA will hear again from patients and advocacy groups, such as I AM ALS, which has lobbied the FDA and Congress for more than two years to make the drug available. The group’s founder, Brian Wallach, said ALS patients, physicians and researchers believe that the company’s data warrants approval.
"Patients do their homework– we know this isn’t going to cure us," said Wallach, who was diagnosed with ALS in 2017 and spoke through an interpreter. "But we also know it might keep us here until the next drug comes along and that one might be a cure."
Wallach currently takes the part of Amylyx’s treatment that is available as a dietary supplement.
Despite the negative FDA review, there are several outside developments that could tip the FDA toward approval.
In June, Canadian regulators approved the drug for ALS patients, the first country to do so. That decision puts FDA regulators in a "precarious position," says bioethicist Holly Fernandez-Lynch.
"They typically like to be out ahead when making approval decisions," said Fernandez-Lynch, who teaches at the University of Pennsylvania. "They like to make the argument that they are not a barrier to patients accessing things that might help them."
Shares of Amylyx fell more than 23% to close at $18 in trading Friday.
——
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.
Track COVID-19 cases, hospitalizations and wastewater numbers across Canada
How do Canadian provinces and territories compare to American states?
Curious how different countries are faring? Chart and compare the curves using our interactive graphs
Sign up to receive the most important updates in your inbox two times a week
RCMP in Saskatchewan issued a dangerous persons alert Sunday morning in connection with multiple reports of stabbings.

The Municipality of Jasper in Alberta's Rocky Mountains temporarily lost power Sunday evening after a massive wildfire impacted transmission lines.

Canada had to find a different way to win a women's world hockey title after its Olympic triumph earlier this year and world championship gold a year ago.

Bed Bath & Beyond Inc.'s chief financial officer fell to his death from New York's Tribeca skyscraper known as the 'Jenga' tower on Friday afternoon, police said, just days after the company said it was closing several stores.

Halifax Regional Police has identified the victim as 36-year-old Patrick Wayne Stay and ruled his death a homicide.

Cannabis does not make you unmotivated, but could potentially lead you to enjoy yourself more, a new study has found.

European leaders on Sunday sought to ease the impact of high energy prices across the continent, after Ukrainian President Volodymyr Zelenskyy warned of a difficult winter, even as he reported progress in a counteroffensive against Russian troops.

Scientists are urging world leaders to act in order to protect the planet's threatened trees, and prevent further ecological and economic damage from their extinction.

Irene Gakwa's last WhatsApp video call with her parents was filled with gentle ribbing. But beneath the banter were hints that something was off. Now, her family is struggling between hope and grief.

RCMP in Saskatchewan issued a dangerous persons alert Sunday morning in connection with multiple reports of stabbings.

Halifax Regional Police has identified the victim as 36-year-old Patrick Wayne Stay and ruled his death a homicide.

The Municipality of Jasper in Alberta's Rocky Mountains temporarily lost power Sunday evening after a massive wildfire impacted transmission lines.

The Toronto Air Show was cancelled on Sunday due to poor weather conditions.

Student leaders say excitement is high as Ontario universities prepare to host the first frosh weeks, largely in-person and absent of public health restrictions, since the COVID-19 pandemic began.

Petro Yankovskyi and his family are starting their new life in Canada, seeking safety after the Russian invasion of Ukraine. But unlike most Ukrainian refugees, the Yankovskyis had fled their home in Russia, not Ukraine.

Pope Francis says he has taken it on himself to rid the Catholic Church of sexual abuse, telling CNN's partner channel CNN Portugal that he was 'responsible that it doesn't happen anymore.'

Former Soviet leader Mikhail Gorbachev, who launched drastic reforms that helped end the Cold War and precipitated the breakup of the Soviet Union, was buried Saturday after a farewell ceremony attended by thousands of mourners but snubbed by Russian President Vladimir Putin.

Irene Gakwa's last WhatsApp video call with her parents was filled with gentle ribbing. But beneath the banter were hints that something was off. Now, her family is struggling between hope and grief.

An executive at Black Lives Matter Global Network Foundation (GNF), is accused of "syphoning" more than $10 million from donors, the grassroots arm of the BLM organization said a court filing this week.

Hillary Clinton revealed that the origins of her trademark penchant for pantsuits trace back to "suggestive" photos from a public appearance in Brazil that ultimately led to her photo being used in lingerie advertisements.

The Liberals and Conservatives are headed for a showdown in Ottawa this fall over the hottest political files of the summer, with both parties making plans to prioritize issues like inflation and travel woes.

The inquiry into Ottawa's unprecedented use of the Emergencies Act during protests last winter will be delayed until October because of a health issue. The Public Order Emergency Commission was to begin hearings Sept. 19 but will be delayed now until Oct. 13, a statement from the commission said Friday.

Former Conservative leader Erin O'Toole will deliver a greeting at the party's leadership event where his successor will be named but he won't be on the stage.

From patient waiting rooms to the halls of Congress, the language being used to talk about reproduction is shifting.

Wendy's restaurants have been associated with an E. coli outbreak now reported in six states, with 97 people infected, the U.S. Centers for Disease Control and Prevention said in an update Thursday.

Cannabis does not make you unmotivated, but could potentially lead you to enjoy yourself more, a new study has found.

Scientists at the Florida Aquarium have made a breakthrough in the race to save Caribbean coral: For the first time, marine biologists have successfully reproduced elkhorn coral, a critical species, using aquarium technology.

Facing rising costs and labour shortages, hospitality is searching for high-tech solutions to serve up quality service to patrons — and robotics companies are answering the call.

NASA's decision to scrub the launch of its new moon rocket is disappointing but necessary due to another leak found ahead of the planned test flight, Canadian astronaut David Saint-Jacques said Saturday.

Canadian pop singer The Weeknd cut short a concert in California on Saturday after he lost his voice mid-performance.

Former U.S. president, Barack Obama won an Emmy Award on Saturday to go with his two Grammys.

“Spider-Man: No Way Home” has swung back on top of the box office during a holiday weekend where American theatres aimed to lure moviegoers with discounted $3 tickets.

A return-to-office showdown is unfolding in Canada and pitting some bosses and workers against each other as the back-to-school season brings with it a renewed push to get employees back into office buildings.

Many major retailers slashed their financial outlooks for the year after seeing shoppers pull back on many discretionary items in the latest quarter. But among the notable exceptions: beauty.

Citing an 'immediate threat to human life,' Cloudflare has dropped the notorious stalking and harassment site Kiwi Farms from its internet security services following an online campaign started by transgender Twitch streamer Clara Sorrenti to pressure it to do so.

Many major retailers slashed their financial outlooks for the year after seeing shoppers pull back on many discretionary items in the latest quarter. But among the notable exceptions: beauty.

A family of Bigg's killer whales, or transient orcas, were spotted swimming in the Victoria Inner Harbour Friday morning. The pod of five orcas came into the harbor around 10 a.m., delighting onlookers and causing boats in the harbour to come to a standstill. A video of the orcas was captured by Orca Spirit Adventures, a whale watching company based out of Victoria.

a Vancouver woman who created a 'Hobbit Hole' in her backyard is now opening it up to anyone who needs some solitude or a brief escape.

Canada had to find a different way to win a women's world hockey title after its Olympic triumph earlier this year and world championship gold a year ago.

Ottawa's Gabriela Dabrowski and Mexican partner Giuliana Olmos have advanced to the women's doubles quarterfinals of the U.S. Open.

It's been a big week for NHL forward J.T. Miller, who welcomed his first son before signing a seven-year contract extension with the Vancouver Canucks worth $56 million.

Video has emerged showing a Tesla driver appearing to be asleep behind the wheel while travelling more than 100 km/h on a busy Ontario highway.

Ontario drivers may soon find themselves on the province's first-ever diverging diamond interchange that is set to open this year.

Formula One leader Max Verstappen returns home to his Orange Army of fans at the Dutch Grand Prix this weekend, with another world title approaching ominously and a different award already in hand.